Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Global Study Identifies Safer Acute Stroke Treatment

May 10, 2016 8:33 am | by University of Leicester | News | Comments

The safety of a controversial clot-busting drug has been investigated by researchers.

TOPICS:

Study Suggests New Treatment for Seizures

May 10, 2016 8:30 am | by eLife | News | Comments

Researchers have discovered a new factor in the escalation of seizures.

TOPICS:

Immunotherapy Drug Shows Long-Lasting Response in Advanced Melanoma

May 9, 2016 3:41 pm | by UCLA | News | Comments

Pembrolizumab produces positive responses that are long-lasting and with fewer side effects than traditional treatments in people with advanced melanoma.

TOPICS:
Advertisement

Gut-Brain Connection Moves into MS Territory

May 9, 2016 1:59 pm | by Harvard Gazette | News | Comments

Evidence suggests that bacteria living in the gut may remotely influence the activity of cells in the brain.

TOPICS:

RNAi-Based Therapeutics: A Novel Platform for Drug Development

May 9, 2016 10:18 am | by Geert Cauwenbergh, Dr. Med. Sc, President and CEO of RXi Pharmaceuticals Corporation | Articles | Comments

The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics. 

TOPICS:

Providing Safe, Targeted Drug Delivery to Placenta During Pregnancy

May 9, 2016 9:44 am | by University of California - Santa Barbara | News | Comments

More than 10 percent of pregnant women develop serious complications during pregnancy. The underlying cause is often a poorly functioning placenta, the organ that nourishes and maintains the fetus.

TOPICS:

Allergan, Richter: Positive Phase 3 Results for Uterine Fibroids Treatment

May 9, 2016 9:37 am | News | Comments

Phase 3 study met all co-primary and secondary endpoints and achieved statistically significant results.

TOPICS:

Antidepressant Use During Pregnancy May Lengthen Umbilical Cord

May 9, 2016 9:29 am | by PLOS ONE | News | Comments

Umbilical cords of children whose mothers used selective serotonin reuptake inhibitors during pregnancy may be longer than umbilical cords of other newborn children, shows a new study.

TOPICS:
Advertisement

Intarcia Preps FDA Filing for Revolutionary Diabetes Drug

May 9, 2016 9:28 am | by Ryan Bushey, Digital Editor | Articles | Comments

More than 4,000 type 2 diabetes patients took part in this placebo-controlled global study over the course of three years.

TOPICS:

E-Cigarette Poisonings Surge in Young Children, Study Says

May 9, 2016 9:22 am | by Lauren Neergaard, AP Medical Writer | News | Comments

Electronic cigarettes have sickened rising numbers of young children, a study of U.S. poison center calls has found. Most cases involve swallowing liquid nicotine.

TOPICS:

Drug-like Peptides Show Promise in Treating 2 Blood Diseases

May 6, 2016 3:30 pm | by Children's Hospital of Pennsylvania | News | Comments

New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults.

TOPICS:

A New Paper-Based Test for the Zika Virus

May 6, 2016 2:30 pm | by Anne Trafton, MIT News Office | News | Comments

The test can be stored at room temperature and read with a simple electronic reader.

TOPICS:

Valeant Forms Internal Committee to Oversee Drug Pricing

May 6, 2016 1:30 pm | by Deena Beasley, Reuters | News | Comments

The committee is made up of a team of Valeant employees including doctors, scientists and other executives.

TOPICS:

NICE Recommends Praluent, Repatha for Treating Cholesterol

May 6, 2016 12:55 pm | News | Comments

The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.

TOPICS:

Long-Term Warfarin Use for AF Linked to Dementia Risk

May 6, 2016 12:10 pm | by Stephanie Guzowski, Editor | News | Comments

Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading